Markella V. Zanni

• Massachusetts General Hospital

  Distinguished physician

Sources: reporter.nih.gov

• National Heart, Lung, and Blood Institute

  R01, Effects of SGLT2 Inhibition on Coronary Flow Reserve and Other Key Indices Relevant to Type 2 Myocardial Infarction Risk among Women with HIV, R01HL170905, 2024–2029, 7 Sept 2026

• National Heart, Lung, and Blood Institute

  R01, Myocardial Fibrosis and Steatosis Burden and Region-Specific Predictors of Progression among ART-treated Women with HIV infection in sub-Saharan Africa (The MUTIMA Study), R01HL167645, 2023–2027, 28 Aug 2026

• National Heart, Lung, and Blood Institute

  R34, Preparing for Semaglutide Microdosing to Maintain Cardiovascular Health in People with HIV: The (pre-)SMASH CVD Trial, R34HL182386, 2026–2029, 8 Jul 2026

• National Institute of Diabetes and Digestive and Kidney Diseases

  R01, Incretin Microdosing for Cardiometabolic Health in People With HIV: The REINFORCE Trial, R01DK142171, 2025–2028, 10 Sept 2025

Sources: reporter.nih.gov